Figure 5.

Comparison between different treatments. Markers expression of osteosarcoma treatment with cMSCs, rhBMP2 and cMSCs treated with rhBMP2 (5 nM) 120 h after treatment analyzed by flow cytometry. Statistical differences were obtained by analysis of variance (*** p < 0.001, ** p < 0.01).

Grassi Rici et al. BMC Veterinary Research 2012 8:17   doi:10.1186/1746-6148-8-17
Download authors' original image